title: Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
abstract: Human cerebrospinal fluid (CSF) inhibits the Na+/K+ pump in human red cells and the activity of purified Na+/K+-ATPase (Halperin, J. A., Shaeffer, R., Galvez, L., and Malavé, S. (1985) Proc. Natl. Acad. Sci. U.S. A. 80, 6102-6104, 1983; Halperin, J. A., Martin, A. M., and Malavé, S. (1985) Life Sci. 37, 561-566. We describe here some properties of the CSF inhibitor of the Na+/K+ pump. Active material was extracted from human CSF with 50% methanol and then concentrated and desalted by ultrafiltration. This extract inhibited, in a dose-dependent manner, the ouabain-sensitive influx of K+ into human red cells and the activity of purified Na+/K+-ATPase. Partial separation of the inhibitory activity was achieved by gel filtration and reverse-phase high performance liquid chromatography. Inhibition of both pump and enzyme was specific in that other red cell membrane transport systems or enzymes examined were not influenced by CSF extracts. Dialysis and ultrafiltration experiments indicate that the molecular weight of the inhibitor is approximately equal to 600. The inhibitory activity is sensitive to proteolytic enzymes indicating that the inhibitor might be a small peptide. In the presence of CSF extract the K0.5 for external K+ to stimulate the Na+/K+ pump increased from 1.4 to 3.1 mM, suggesting that the CSF inhibitor competes with external K+ for stimulation of the pump. We estimate that the concentration of the inhibitor in CSF might be approximately equal to 50 pg/ml, a value close to the concentration of other active peptides found in human CSF.
authors.affiliation: Department of Physiology and Biophysics, Harvard Medical School, Boston, Massachusetts 02115.
authors.forename: J A
authors.initials: JA
authors.lastname: Halperin
authors.forename: J F
authors.initials: JF
authors.lastname: Riordan
authors.forename: D C
authors.initials: DC
authors.lastname: Tosteson
mesh_terms: D002556:Cerebrospinal Fluid Proteins / Q000302:isolation & purification* / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008970:Molecular Weight; D010042:Ouabain / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000378:metabolism; D011188:Potassium / Q000097:blood / Q000494:pharmacology; D012413:Rubidium / Q000097:blood; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D014462:Ultrafiltration
chemical_list: D002556:Cerebrospinal Fluid Proteins; D010042:Ouabain; D010447:Peptide Hydrolases; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium; D011188:Potassium